Appen share price surges 20% higher on impressive full year result

The Appen Ltd (ASX:APX) share price has surged 20% higher to another all-time high following the release of an impressive full year result…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been a stunning start to the week for the Appen Ltd (ASX: APX) share price.

This morning the shares of the global leader in the development of high-quality, human annotated datasets for machine learning and artificial intelligence rocketed 20% higher to an all-time high of $22.50.

At present they are trading almost 19% higher at $22.33.

Why did the Appen share price rocket higher today?

This morning Appen released its highly anticipated full year results which smashed both the company's guidance and the market's expectations.

In FY 2018 the company delivered underlying EBITDA of $71.3 million, up a staggering 153% on the prior corresponding period.

Incredibly, this was also 10% higher than the top end of the upgraded guidance range it provided in mid-November when there were just six weeks left of its financial year.

Appen's Content Relevance division did the majority of the heavy lifting. On a statutory basis, the key segment delivered a 148% increase in revenue to $312.8 million. This was driven partly by the acquisition of the Leapforce business, but also by existing and new customer investments in artificial intelligence.

In addition to this, economies of scale contributed to margin expansion during the half, leading to segment EBITDA growing a whopping 238%. This ultimately led to Appen's overall underlying EBITDA margin improving to 19.6% from 16.9% in the prior corresponding period.

It also offset a subdued performance by Appen's Language Resources division. Although the segment posted a 27% increase in revenue to a record $51.4 million, segment EBITDA declined by a disappointing 8.2% to $11.2 million. Management blamed the margin decline on its mix of work.

What's next for Appen?

The good news for shareholders is that management is confident that its growth can continue in FY 2019 and beyond.

It has pointed to the booming AI market as a reason to be positive. This market is expected to be worth $191 billion by 2025, with 10% of it estimated by the McKinsey Global Institute to be related to labelled data that Appen is directly involved in.

In order to gain exposure to as much as this addressable market as possible, the company has advised that it is building out its team, customer base, and operations in the world's second biggest AI market, China.

In the short term management has provided underlying EBITDA guidance in the range $85 million to $90 million, which will be a year on year increase of between 19.2% and 26.2%.

Should you invest?

Whilst its shares are looking fairly valued now, I still feel that its long-term growth prospects make it a good buy and hold option along with fellow tech stars Afterpay Touch Group Ltd (ASX: APT) and Altium Limited (ASX: ALU).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO, Altium, and Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »